USPTO 2015–2025 USPTO PatentsView US Corporation

Mount Sinai School of Medicine

USPTO PatentsView assignee record - 7 granted patents across 7 technology areas, recorded in grant years 2015–2022. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

RSS updates for this company

The verdict

According to USPTO PatentsView, Mount ranks #36,560 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 7 technology areas.

#36,560
of 49,997 US assignees by volume
40th percentile
by Innovation Score (32.1/100)
14.9
avg claims per patent
-60%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R36560 · US Corporation #36,560 · 7 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MICRO 7 grants
  • MID-PACK #36,560/49,997
  • PHOTO-FINISH Mossey Creek
  • CPC-NARROW C12N · 7 areas
  • INNOV-THIN 32.1/100
  • CLAIMS-RICH 14.9 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-DROP -60% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Mossey Creek Technologies Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Mount’s 32.1 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Mount

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Mount's Innovation Score is 32.1/100 (40th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Mount?

Each dot is one of Mount’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Mount’s own 14.9 claims/patent is at or below the 16.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Mount vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 6.97.07.077.07.07.1 51015202530 Granted patents (volume) Avg claims / patent Mossey Creek Technologies Inc. - 7, 16.29Mossey CreekMosway Technologies Limited - 7, 17.57MoswayMotion Engine Inc. - 7, 27.86Motion EngineMotus Integrated Technologies - 7, 16Motus IntegratedMozilla Corporation - 7, 16.43MozillaMul-T-Lock Technologies Ltd. - 7, 9.86Mul-t-lockMultimorphic, Inc. - 7, 15.43MultimorphicMultiple Energy Technologies LLC - 7, 15.43Multiple EnergyMount Sinai School of Medicine - 7, 14.86Mount Sinai Schoo…
Mount vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Mount's grants concentrate

Mount Sinai School of Medicine is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2016 (3 grants) versus a trough of 1 in 2015. By volume, Mount sits between Mossey Creek Technologies Inc. and Multiple Energy Technologies LLC.

Mount's three-year grant acceleration

Mount Sinai School of Medicine shows 1 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Mount's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Mount holds 7 patents at rank #36,554, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Mount

By rank, the assignees closest to #36,554 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Mount's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Mount, neither rank-band nor same-CPC leaders (those blocks stay above). In C12N (Microorganisms OR Enzymes), Mount ranks #1,382 of 4,144 assignees by patent count in that subclass.

Mount's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 40th percentile higher than 40% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.533.5 20152016201720202022 1
USPTO utility patent grants by year · 2015–2022

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Mount Sinai School of Medicine patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 14.3%
2016 3 42.9%
2017 1 14.3%
2020 1 14.3%
2022 1 14.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Mount Sinai School of Medicine's patent record in context - here's where to go next.

  • Mount Sinai School of Medicine's lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 100% of its portfolio - see every assignee active in that class. Explore C12N
  • Ranked #36,560 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Mount Sinai School of Medicine against Mossey Creek Technologies Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 32.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.